关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nifdc.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  1 3 1 4 8 6 9 4 位浏览者
您当前的位置:首页 >> 正文

高效液相色谱测定盐酸决奈达隆片含量及有关物质

HPLC determination of dronedarone hydrochloride tablets and its related substances

分类号:
出版年·卷·期(页码):2013,33 (3):0-0
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的:应用高效液相色谱技术,建立盐酸决奈达隆片含量测定和有关物质检查的方法。 方法:采用Agilent ZORBAX Eclipse Plus C18色谱柱(100 mm×4.6 mm,3.5 μm),以2 mmol·L-1磷酸二氢钠溶液(以氢氧化钠溶液调至pH 7.0)-甲醇-乙腈(20: 30: 50)为流动相,流速1.5 mL·min-1,检测波长290 nm。 结果:决奈达隆的线性相关系数(r)为1.000;检出限为0.19 mg·L-1;回收率在101.4%~101.6%之间;精密度和12 h稳定性的RSD均小于1%;决奈达隆和辅料及强制降解产物之间都有良好的分离度。 结论:该方法可作为盐酸决奈达隆片含量测定和有关物质检查的方法。

-----英文摘要:---------------------------------------------------------------------------------------

Objective: To establish an HPLC method for the determination of dronedarone hydrochloride tablets and its related substances. Method: An Agilent ZORBAX Eclipse Plus C18 column (100 mm×4.6 mm,3.5 μm) was used for the separation,with 2 mmol·L-1 sodium dihydrogen phosphate (adjusted pH to 7.0 with sodium hydroxide solution)-methanol-acetonitrile (20: 30: 50) as the mobile phase at the flow rate of 1.5 mL·min-1.The detection wavelength was 290 nm. Results: The correlation coefficient(r) of dronedarone was 1.000;the LOD was 0.19 mg·L-1;the spiked recovery ranged from 101.4% to 101.6%;the relative standard deviations(RSDs) of the precisions and the 12 h stability were both below 1%;satisfactory resolutions between dronedarone,excipients and forced degradation products were achieved. Conclusion: This method can be used for the determination of dronedarone hydrochloride tablets and its related substances.

-----参考文献:---------------------------------------------------------------------------------------
1 TANG Zhong-ming(汤仲明).Introduction to the U.S.FDA's new drug approvals in 2009 (2009年美国FDA批准新药介绍).J Int Pharm Res(国际药学研究杂志),2010,37(1):8
2 WANG Guan(王冠),ZHANG Fei-long(张飞龙),WANG Jia-jing(王佳静),et al.Synthesis of dronedarone hydrochloride(盐酸决奈达隆的合成).Chin J Pharm(中国医药工业杂志),2011,42(12):881
3 LIU Yu-li(刘玉丽),WANG Yu-mei(汪玉梅),HU Yong-liang(胡永亮),et al.Synthesis of related substance of dronedorone(决奈达隆有关物质的合成).Chin J Pharm(中国医药工业杂志),2012,43(7):535
4 LIU Jing(刘璟),QIN Yong-wen(秦永文).Dronedarone:a novel antiarrhythmic drug for the treatment of atrial fibrillation(决奈达隆:治疗房颤的新型抗心律失常药).Pharm Care Res(药学服务与研究),2008,8(6):417
5 ZHANG Jie(张杰),ZHANG Nan(张楠),GE Hai-tao(葛海涛).Dronedarone for the treatment of atrial fibrillation(心房颤动治疗药物决奈达隆).World Clin Drug(世界临床药物),2009,30(12):765
6 SHI Wei(石伟),SHAO Jiang(邵江),PANG Xiao-hua(庞小华),et al.Meta-analysis on dronedarone in treatment of atrial fibrillation or atrial flutter(决奈达隆治疗房颤/房扑临床试验荟萃分析).China Pharm(中国药房),2010,21(30):2852
7 LEI Zhao-bao(雷招宝).Adverse reactions and interactions of the antiarrhythmic drug dronedarone(抗心律失常新药决奈达隆的不良反应与相互作用).Chin J New Drug(中国新药杂志),2012,21(15):1826
8 YANG Shi-lei(杨世磊),DAI Xiao-jian(戴晓健),TANG Xin-qiang(汤新强),et al.Determination of dronedarone and it's metabolite SR35021 in dog plasma by LC-MS/MS(犬血浆中决奈达隆及其代谢物SR35021的LC-MS/MS法测定).Chin J Pharm(中国医药工业杂志),2011,42(7):525
9 ChP(中国药典).2010.Vol Ⅱ(二部):770

欢迎阅读《药物分析杂志》!您是该文第 1857位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn